dc.contributor.author
Hanitsch, Leif Gunnar
dc.date.accessioned
2026-01-07T08:24:53Z
dc.date.available
2026-01-07T08:24:53Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/50898
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-50625
dc.description.abstract
Common variable immunodeficiency disorders (CVID) are the most frequent clinically relevant primary immunodefiency. Despite impaired humoral immunity, robust T cellular immune responses after SARS-CoV-2 infection and after COVID-19 and influenzavaccination were found. Quality and logevity of antibody responses to COVID-19 mRNA vaccination is significantly impaired in CVID patients.
en
dc.rights.uri
http://www.fu-berlin.de/sites/refubium/rechtliches/Nutzungsbedingungen
dc.subject
vaccinations
en
dc.subject
immunodeficiency
en
dc.subject
immune response
en
dc.subject.ddc
600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::610 Medizin und Gesundheit
dc.title
T-Zellen bei common variable immundeficiency disorder (CVID)
dc.contributor.gender
male
dc.contributor.firstReferee
N.N.
dc.contributor.furtherReferee
N.N.
dc.date.accepted
2025-12-08
dc.identifier.urn
urn:nbn:de:kobv:188-refubium-50898-8
dc.title.subtitle
T-zelluläre Immunität in COVID-19 und Influenza-Impfung sowie die Rolle von T-Zellen als Auslöser von Immundysregulation
dc.title.translated
T cells in common variable immunodeficiency disorders
en
refubium.affiliation
Charité - Universitätsmedizin Berlin
dcterms.accessRights.dnb
free
dcterms.accessRights.openaire
open access
dcterms.accessRights.proquest
accept
